Morphological and molecular heterogeneity in renal cell cancer is exacerbated by treatment with sunitinib

被引：0
|
作者：
Stewart, G. D. [1 ]
O'Mahony, F. C. [1 ]
Eory, L. [1 ]
Laird, A. [1 ]
Peters, J. [1 ]
Riddick, A. C. P. [1 ]
McNeill, S. A. [1 ]
Aitchison, M. [1 ]
Overton, I. M. [1 ]
Harrison, D. J. [1 ]
Powles, T. [1 ]
机构：
[1] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland
来源：
BJU INTERNATIONAL | 2013年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P112
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [1] Sunitinib Treatment Exacerbates intratumoral Heterogeneity in Metastatic Renal Cancer
    Stewart, Grant D.
    O'Mahony, Fiach C.
    Laird, Alexander
    Eory, Lel
    Lubbock, Alexander L. R.
    Mackay, Alan
    Nanda, Jyoti
    O'Donnell, Marie
    Mullen, Peter
    McNeill, S. Alan
    Riddick, Antony C. P.
    Berney, Daniel
    Bex, Axel
    Aitchison, Michael
    Overton, Ian M.
    Harrison, David J.
    Powles, Thomas
    CLINICAL CANCER RESEARCH, 2015, 21 (18) : 4212 - 4223
  • [2] COMPLIANCE WITH SUNITINIB TREATMENT IN PATIENTS WITH RENAL CELL CANCER
    De Both, A.
    Kruse, V.
    De Coene, E.
    Clottens, N.
    Somers, A.
    van Belle, S.
    van Bortel, L.
    Rottey, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 287 - 287
  • [3] Sunitinib and everolimus for the treatment of a patient with clear cell renal cancer
    Bodnar, Lubomir
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 : C7 - C8
  • [4] Renal Cell Carcinoma before and after Sunitinib Therapy. Morphological and Molecular Changes
    Doshi, R.
    O'Donnell, M.
    Bex, A.
    Beltran, L.
    Sahdev, A.
    Peters, J.
    Harrison, D. J.
    Stewart, G. D.
    Powles, T.
    Berney, D. M.
    MODERN PATHOLOGY, 2012, 25 : 201A - 201A
  • [5] Renal Cell Carcinoma before and after Sunitinib Therapy. Morphological and Molecular Changes
    Doshi, R.
    O'Donnel, M.
    Bex, A.
    Beltran, L.
    Sahdev, A.
    Peters, J.
    Harrison, D. J.
    Stewart, G. D.
    Powles, T.
    Berney, D. M.
    LABORATORY INVESTIGATION, 2012, 92 : 201A - 201A
  • [6] The effect of sunitinib on biomarkers and tumor heterogeneity in metastatic clear cell renal cancer.
    Stewart, Grant
    Laird, Alexander
    O'Mahony, Fiach
    Eory, Lel
    Lubbock, Alexander
    Nanda, Jyoti
    O'Donnell, Marie
    Mackay, Alan
    Mullen, Peter
    McNeill, Alan
    Riddick, Antony
    Aitchison, Michael
    Berney, Daniel
    Bex, Axel
    Overton, Ian
    Harrison, David James
    Powles, Tom
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [7] Sunitinib for advanced renal cell cancer
    Coppin, Chris
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (01): : 97 - 105
  • [8] Sunitinib for treatment of advanced renal cell cancer: Primary tumor response
    Van der Veldt, Astrid A. M.
    Meijerink, Martijn R.
    Van den Eertwegh, AlfonsJ. M.
    Bex, Axel
    Gast, Gijsbert Cle
    Haanen, John B. A. G.
    Boven, Epie
    CLINICAL CANCER RESEARCH, 2008, 14 (08) : 2431 - 2436
  • [9] Treatment of Metastatic Renal Cell Cancer With Sunitinib During Chronic Hemodialysis
    Zastrow, Stefan
    Froehner, Michael
    Platzek, Ivan
    Novotny, Vladimir
    Wirth, Manfred P.
    UROLOGY, 2009, 73 (04) : 868 - 870
  • [10] Metastasised renal cell cancer - Study with Sunitinib in first line treatment
    不详
    UROLOGE, 2007, 46 (03): : 345 - 345
12345